NanoSphere Health Sciences Inc (TSE:NSHS)
:NSHS
Want to see TSE:NSHS full AI Analyst Report?
NSHS Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.06
Previous CloseN/A
Volume0.00
Average Volume (3M)9.76K
Market Cap
C$205.50K
Enterprise ValueC$203.98K
Total Cash (Recent Filing)C$1.88K
Total Debt (Recent Filing)C$57.14K
Price to Earnings (P/E)―
Beta-3.55
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding10,275,205
10 Day Avg. Volume800
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.14
Price to Sales (P/S)0.00
P/FCF Ratio-8.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Narrowing Cash BurnNarrowing cash burn reduces near-term funding pressure and extends operational runway, giving management more time to advance development milestones. This durable improvement lowers refinancing frequency and preserves strategic optionality for partnerships or staged financing.
Low Absolute DebtModest absolute debt limits fixed financing obligations and interest exposure, improving financial flexibility versus leveraged peers. Structurally, lower debt reduces near-term default risk and leaves capacity to access non-dilutive or staged financing to support development programs.
Operating Loss Improvement (2020–2024)A multi-year reduction in operating losses suggests improving cost control or program efficiency, which can materially lower cash needs over time. If sustained, this trend de-risks the path to commercialization and enhances the durability of future funding requirements.
Bears Say
Pre-revenue CompanyNo reported revenue indicates the company is pre-commercial, lacking product-market validation and recurring cash inflows. Structurally this creates long timelines to profitability, high execution risk, and persistent dependence on external capital to fund operations and trials.
Deeply Negative Shareholders' EquityConsistently negative equity reflects accumulated deficits that weaken the capital base and heighten solvency concerns. This structural imbalance constrains financing options, increases refinancing risk, and often forces dilutive raises or complex balance-sheet fixes over the medium term.
Persistent Negative Cash FlowOngoing negative operating and free cash flow mandates continuous external funding, undermining self-sufficiency. Over the medium term this increases dilution or debt risk, limits investment flexibility, and places execution of R&D and commercialization plans at the mercy of financing availability.
NSHS FAQ
What was NanoSphere Health Sciences Inc’s price range in the past 12 months?
NanoSphere Health Sciences Inc lowest stock price was C$0.02 and its highest was C$0.06 in the past 12 months.
What is NanoSphere Health Sciences Inc’s market cap?
NanoSphere Health Sciences Inc’s market cap is C$205.50K.
When is NanoSphere Health Sciences Inc’s upcoming earnings report date?
NanoSphere Health Sciences Inc’s upcoming earnings report date is Jun 03, 2026 which is in 8 days.
How were NanoSphere Health Sciences Inc’s earnings last quarter?
Currently, no data Available
Is NanoSphere Health Sciences Inc overvalued?
According to Wall Street analysts NanoSphere Health Sciences Inc’s price is currently Overvalued.
Does NanoSphere Health Sciences Inc pay dividends?
NanoSphere Health Sciences Inc does not currently pay dividends.
What is NanoSphere Health Sciences Inc’s EPS estimate?
NanoSphere Health Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoSphere Health Sciences Inc have?
NanoSphere Health Sciences Inc has 10,275,205 shares outstanding.
What happened to NanoSphere Health Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NanoSphere Health Sciences Inc?
Currently, no hedge funds are holding shares in TSE:NSHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NanoSphere Health Sciences Inc
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.